Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Equity Ratio (2019 - 2025)

Pulmonx (LUNG) has disclosed Equity Ratio for 7 consecutive years, with 0.43 as the latest value for Q3 2025.

  • Quarterly Equity Ratio fell 22.62% to 0.43 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.43 through Sep 2025, down 22.62% year-over-year, with the annual reading at 0.53 for FY2024, 20.82% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.43 at Pulmonx, down from 0.52 in the prior quarter.
  • The five-year high for Equity Ratio was 0.85 in Q1 2021, with the low at 0.43 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.68, with a median of 0.67 recorded in 2024.
  • The sharpest move saw Equity Ratio fell 3.23% in 2022, then fell 23.25% in 2025.
  • Over 5 years, Equity Ratio stood at 0.82 in 2021, then dropped by 3.23% to 0.8 in 2022, then decreased by 16.31% to 0.67 in 2023, then decreased by 20.82% to 0.53 in 2024, then dropped by 17.61% to 0.43 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.43, 0.52, and 0.53 for Q3 2025, Q1 2025, and Q4 2024 respectively.